Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

4-amino-5-oxo-4 (pyridinium-1-ylmethyl) proline

EU orphan designation number: EU/3/06/356   
Active ingredient: 4-amino-5-oxo-4 (pyridinium-1-ylmethyl) proline
Indication: Treatment of renal cell carcinoma
Sponsor: Prodimed S.A.
C/ Guzman el Bueno, 74. 1°, E-25015 Madrid, España

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/02/2006 Centralised Orphan - Designation EMEA/OD/085/05 (2006)547 of 16/02/2006
18/08/2010 Other procedure EMA/410144/2010